Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 20, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC | NASDAQ | Diagnostics & Research | A | $50.70B | $634.90 | 1.39% | $1.45B | 49.91x | 1.17 | United States | 50 |
| LTM | LATAM AIRLINES GROUP SA | NYSE | Airlines | A | $36.41B | $60.23 | -0.48% | $1.88B | 18.64x | 20.11 | Chile | 32 |
| JLL | JONES LANG LASALLE INC | NYSE | Real Estate Services | A | $14.84B | $314.42 | 9.62% | $1.16B | 23.61x | 1.38 | United States | 43 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.25B | $168.72 | 0.44% | $182.64M | -28.17x | 1.87 | Ireland | 16 |
| BCO | BRINKS CO | NYSE | Security & Protection Services | A | $5.39B | $129.82 | 0.00% | $806.70M | 32.54x | 24.42 | United States | 44 |
| VISN | VISTANCE NETWORKS INC | NASDAQ | Communication Equipment | A | $4.19B | $18.91 | -0.99% | $1.70B | 4.61x | -3.84 | United States | 24 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $2.89B | $36.61 | 1.61% | $57.00M | 93.87x | 0.09 | United States | 45 |
| DBD | DIEBOLD NIXDORF INC | NYSE | Software - Application | A | $2.84B | $80.69 | -2.29% | $331.90M | 31.40x | 2.50 | United States | 42 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.04B | $157.51 | -1.56% | $301.16M | 9.13x | 1.82 | United States | 50 |
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | A | $1.77B | $23.66 | -0.80% | $214.76M | 12.52x | 0.42 | United States | 45 |
| ATRC | ATRICURE INC | NASDAQ | Medical Instruments & Supplies | A | $1.60B | $32.26 | -2.15% | -$1.75M | -52.89x | 0.33 | United States | 29 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.26B | $49.37 | 12.64% | $122.10M | 41.84x | 1.11 | United States | 38 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $951.14M | $3.30 | -0.30% | $137.29M | 41.25x | 0.68 | United States | 45 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $878.21M | $31.31 | -2.52% | $174.52M | 7.15x | 5.24 | United States | 39 |
| MNTN | MNTN INC | NYSE | Software - Application | A | $764.45M | $10.44 | 0.48% | N/A | N/A | 0.26 | United States | 13 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $737.31M | $10.14 | 3.47% | $98.00M | 10.45x | 0.23 | United States | 55 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $711.25M | $19.06 | 1.98% | $145.14M | N/A | 6.80 | Mexico | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $566.11M | $18.53 | 1.37% | $86.84M | 50.08x | 2.69 | United States | 31 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $565.15M | $32.53 | -1.21% | $38.00M | 33.19x | 0.95 | United States | 54 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $487.34M | $3.84 | 2.67% | $18.04M | -32.00x | 0.49 | United States | 20 |
| FENC | FENNEC PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $252.21M | $8.97 | 3.34% | -$4.53M | -35.88x | -11.97 | United States | 30 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $220.29M | $5.55 | 2.59% | -$4.74M | -24.13x | 0.64 | United States | 17 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $205.31M | $24.81 | -2.09% | $13.13M | 23.19x | 0.21 | United States | 48 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $157.61M | $7.75 | 1.97% | $24.16M | 29.81x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.